by Jan HENNOP THE HAGUE, Netherlands (AFP) — Pharmaceutical giant Novavax has applied for authorization for their coronavirus vaccine in the EU with a decision possible “within weeks”, Europe’s drugs regulator said Wednesday. The jab, if approved, would be the fifth authorized for use within the EU — the other four are made by Pfizer/BioNTech, AstraZeneca/Oxford, Moderna and Johnson & Johnson. The assessment of the vaccine, which goes under the brand name Nuvaxovid, would be […]